← Open Payments lookup

MICHELE NOVELLA: Open Payments

NPI 1750307948 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$134,139 in 318 payments from 19 companies in 2025. Trend: 2023 $38,079 · 2024 $135,629 · 2025 $134,139

Honoraria: $61,900Travel & lodging: $28,845Speaker / faculty: $22,485Consulting: $8,880Food & beverage: $6,721Speaker / faculty: $5,309
CompanyPaymentsAmount
Axsome Therapeutics, Inc.123$85,317
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)55$29,757
Alkermes, Inc.12$6,333
E.R. Squibb & Sons, L.L.C.10$5,517
Vertical Pharmaceuticals, LLC3$5,330
ABBVIE INC.41$552
Corium, LLC17$253
Takeda Pharmaceuticals U.S.A., Inc.11$233
Vanda Pharmaceuticals Inc.12$233
Otsuka America Pharmaceutical, Inc.19$181

Products named: Auvelity, CAPLYTA, Relexxii, LYBALVI, COBENFY, ARISTADA, VRAYLAR, Azstarys.

Industry payments across CT — which companies pay providers there.